Phase 3 Acute Coronary Syndrome Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled58 locationsNCT07102628
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled223 locationsNCT05918861
Recruiting
Phase 3
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Acute Coronary SyndromeTuberculosisPulmonary Hypertension (Diagnosis)
National University Hospital, Singapore150 enrolled6 locationsNCT05473520
Recruiting
Phase 3
Aggressive Smoking Cessation Trial (ASAP)
Cardiovascular DiseasesAcute Coronary Syndrome
Sir Mortimer B. Davis - Jewish General Hospital798 enrolled13 locationsNCT05257629
Recruiting
Phase 2Phase 3
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Ventricular DysfunctionDiabetesAcute Coronary Syndrome+1 more
University of Sao Paulo80 enrolled1 locationNCT06286878
Recruiting
Phase 3
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Jiangsu vcare pharmaceutical technology co., LTD1,000 enrolled1 locationNCT06577519
Recruiting
Phase 3
Double blind, placebo controlled randomised trial assessing the efficacy of endothelin-1 receptor antagonism in the prevention of microvascular injury in patients with non-ST elevation acute coronary syndrome (NSTEACS) undergoing percutaneous coronary intervention: the ENDORA-PCI trial
Peri-procedural myocardial injury/infarctionNon-ST elevation acute coronary syndrome (NSTEACS)
Prince of Wales Hospital52 enrolled1 locationACTRN12615000709549
Recruiting
Phase 3
The effect of pretreatment with a loading dose of intracoronary adenosine on periprocedural myonecrosis in patients undergoing percutaneous coronary intervention in the setting of non ST segment elevation acute coronary syndrome
Non ST elevation acute coronary syndrome
Monash Medical Center144 enrolled1 locationACTRN12609000342213
Completed
Phase 3Phase 4
Does point of care troponin testing speed up care of cardiac patients in emergency?
Possible Acute Coronary Syndrome in emergency patients
Conrad Loten300 enrolled1 locationACTRN12607000475448
Recruiting
Phase 3
CHAMPION PCI
Myocardial InfarctionAcute Coronary SyndromesUnstable Angina
The Medicines Company9,000 enrolled1 locationACTRN12606000343505
Recruiting
Phase 3
PRACTICAL TRIAL
Acute Coronary Syndromes
Cardiology Dept, Royal Perth Hospital370 enrolled1 locationACTRN12605000581662